One of two of Opthea's phase III trials for a common eye disease has failed to meet its objectives, casting doubts on the ...

New research shows the risk of prostate cancer increases by 45 percent in men who share one common practice. According to the ...

A new study has revealed that men who don't heed recommendations for prostate cancer screenings are at a significantly higher ...

Brother of Linda Nolan reveals prostate cancer diagnosis after sister’s death - Mr Nolan said the diagnosis was like being ...

Men with a family history of prostate cancer should begin screenings at age 40 or even earlier, especially if multiple close relatives have been affected. Research consistently indicates that African ...

As cancer rates rise in younger adults, Eyewitness News has compiled a list of resources to help assess your risk of cancer ...

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone ...

The PSMA-PET imaging agent will be used for patients who have suspected metastasis and those with suspected cancer recurrence.

Telix Pharmaceuticals reported that the U.S. Food and Drug Administration approved its agent indicated for prostate cancer ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food ...